
Gallant's decision to leave Amikam was made after a security risk assessment conducted by the Shin Bet.
Former defense minister Yoav Gallant vacated his home in Moshav Amikam in northern Israel over a year ago, following a threat made against him shortly before the end of his term.
The decision to leave Amikam was made after a security risk assessment conducted by the Shin Bet (Israel Security Agency).
Gallant is currently renting an apartment in Tel Aviv with his wife, Israeli media reported on Friday.
The apartment was described as “luxurious,” though no additional details were provided regarding its size or other specifications.
Gallant evacuated due security threat
Sources familiar with the matter said the Shin Bet's evacuation order was issued due to the location of Gallant's home and the nature of the threat. However, they noted that the level of risk Gallant faces remains exceptionally high.
No details have ever been officially published regarding the nature of the threat or the circumstances surrounding it.
Both Gallant and his wife declined to comment on the matter.
latest_posts
- 1
74 suicide warnings and 243 mentions of hanging: What ChatGPT said to a suicidal teen - 2
Track down the Ideal Weight reduction Methodology for Your Way of life - 3
The Most Compelling Innovation Advancements Somewhat recently - 4
Israel strikes south Lebanon after first direct talks in decades - 5
Are your hormones imbalanced? Doctors explain how to know if you need testing
Internet Bookkeeping Programming for Consultants
Vinicultural Investigation: A Survey of \Enjoying Fine Vintages\ Wine sampling
Instructions to Expand Your Advantages from an Open Record Reward
Presenting Nintendo's New Pastel Satisfaction Con Tones for Switch Gamers: 3 Upscale Choices
Turkey key underlying issue as Israel, Greece, Cyprus hold summit
Picking the Right Home Machines: A Commonsense Aide
Extravagance SUVs for Seniors: Solace, Innovation, and Security
Miley Cyrus flashes a diamond ring on the red carpet, sparking engagement rumors with Maxx Morando: A timeline of their four-year relationship
US FDA declines to approve Corcept's drug for rare hormonal disorder












